focus -WSS

focus

author：entertainment 2025-10-01 17:20:49 - browse：5113

Pfizer and Moderna aren’t the only vaccine money-makers. Much of the revenue and profits from Covid-19 vaccines are flowing behind the scenes, going to the contract manufacturers and clinical-trial organizers that turn the shots from lab-bench theory to mass-produced reality.

Both AstraZeneca and Johnson & Johnson publicly committed to not profiting off their products during the pandemic — though AstraZeneca has reserved the right to declare the pandemic over on July 1, even if the World Health Organization has not. Pfizer and Moderna made no such pledge, with Pfizer expected to make $15 billion in vaccine-related revenue this year, while Moderna is forecasting $18.4 billion in vaccine sales.

Contractors hired to test and manufacture these vaccines have enjoyed a share of the profits without the same level of public scrutiny.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Dems pitch expanding Medicare power to negotiate drug prices

WSS

Takeaways from AdvaMed, the largest medical devices conference

Life sciences deals on track to hit lowest point since 2017

Massive project maps cells in human brain in unprecedented detail

Peter Marks talks Operation Warp Speed for Rare Diseases

Better Therapeutics data on benefit with GLP

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

explore

focus

knowledge

Affirmative action in medical school literally saved lives

Wellcome Trust names Røttingen as its new CEO

Jerome Adams on the need for new antivirals for Covid

How doctors’ personal politics affect patients

New air purifier tech could be key to improving indoor air quality

Researchers CRISPR chickens in bid to protect them from bird flu

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

A fraught question for the kids of Alzheimer’s: Is it coming for us?

Medical leaders decry Supreme Court decision on affirmative action

'Investigate these claims': UFO transparency at center of House hearing

hotspot

Researchers CRISPR chickens in bid to protect them from bird flu

European regulators consider appeal over Amylyx ALS drug

How doctors’ personal politics affect patients

The haunting brain science of long Covid

A new crop of companies is reshaping the health data economy

Former reverend arrested for allegedly killing 8

knowledge

hotspot

focus

focus